Results 1 to 10 of about 41,329 (161)

Identification of immunomodulators associated with atrial fibrillation reporting to better understand AF immunologic mechanisms: a Vigibase retrospective disproportionality analysis and a literature review [PDF]

open access: yesBMJ Open
Objectives Growing evidence exists about the pivotal role of immune mechanisms in the physiopathology of atrial fibrillation (AF). Drugs that modulate the immune system (immunomodulators) may contribute to the development of AF.
Charles Dolladille   +11 more
doaj   +2 more sources

Schistosome immunomodulators.

open access: yesPLoS Pathogens, 2021
Schistosomes are long lived, intravascular parasitic platyhelminths that infect >200 million people globally. The molecular mechanisms used by these blood flukes to dampen host immune responses are described in this review.
Sreemoyee Acharya   +2 more
doaj   +4 more sources

Enteral nutrition versus immunomodulators for induction and maintenance of remission in pediatric Crohn's disease: a systematic review and network meta-analysis [PDF]

open access: yesFrontiers in Pediatrics
BackgroundEnteral nutrition (EN) and immunomodulators are established therapies for pediatric Crohn's disease (CD), yet comparative effectiveness data remain limited.ObjectiveWe conducted a network meta-analysis (NMA) to compare the efficacy and safety ...
Jiajia Chen   +3 more
doaj   +2 more sources

Сell-free pertussis vaccine from antigens of freshly isolated strain of B. pertussis serotype 1.2.3

open access: yesЖурнал микробиологии, эпидемиологии и иммунобиологии, 2020
Aim. Development of technology for the manufacture of cell-free pertussis vaccine (CPV) from a freshly isolated strain of B. pertussis No. 211 serotype 1.2.3 and the study of its protective activity and safety in comparison with the preparation of ...
Evgeniy M. Zaitsev   +4 more
doaj   +1 more source

Anti-Alphaviral Alkaloids: Focus on Some Isoquinolines, Indoles and Quinolizidines

open access: yesMolecules, 2022
The discovery and the development of safe and efficient therapeutics against arthritogenic alphaviruses (e.g., chikungunya virus) remain a continuous challenge.
Anne-Laure Sandenon Seteyen   +5 more
doaj   +1 more source

Vernal Keratoconjunctivitis- A Survey on Practice Patterns and Perspectives of Indian Ophthalmologists [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2021
Introduction: Vernal Keratoconjunctivitis (VKC) is a common chronic allergic condition mostly affecting children and their childhood. At present, the choice of medication varies greatly for the same severity of disease from one ophthalmologist to ...
SHWETHA N CHANDRANNA   +3 more
doaj   +1 more source

Nutritional Immunomodulators

open access: yesExperimed, 2020
“Let food be thy medicine and let medicine be thy food.” This aphorism refers to the pivotal role played by nutrition in medicine. The door of a “nutrition renaissance” has been opened with the striking disclosure of the relationship between nutrition ...
Farhad Kohansal Koshksaray   +3 more
doaj   +1 more source

IMPROVEMENT OF SPECIFIC CHOLERA PREVENTION USING IMMUNOMODULATORS

open access: yesМедицинская иммунология, 2021
It is known that the combined use of vaccines, cytokines and various immunomodulatory drugs contributes to the development of a full-fledged immune response.
A. V. Filippenko   +4 more
doaj   +1 more source

Immune-mediated polyarthritis in dogs: Are corticosteroids the best bet?

open access: yesVeterinary Evidence, 2023
PICO question In dogs with type I immune-mediated polyarthritis (IMPA), is sole treatment with other immunosuppressive agents as effective as treatment with corticosteroids at reducing clinical signs?
Hannah Walker
doaj   +1 more source

Investigational Drugs for the Treatment of Depression (Part 1): Monoaminergic, Orexinergic, GABA-Ergic, and Anti-Inflammatory Agents

open access: yesFrontiers in Pharmacology, 2022
Therapeutic management of depression has currently important limitations, and its low efficacy is reflected in high rates of non-response even after multiple trials of antidepressants. Almost two-thirds of the patients diagnosed with major depression who
Octavian Vasiliu
doaj   +1 more source

Home - About - Disclaimer - Privacy